Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
oral contraceptive |
| gptkbp:activeIngredient |
gptkb:ethinyl_estradiol
norethindrone |
| gptkbp:contraindication |
pregnancy
history of thromboembolic disorders |
| gptkbp:estimatedStrength |
0.035 mg ethinyl estradiol
1 mg norethindrone |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Norinyl-100000
|
| gptkbp:marketedAs |
gptkb:Pfizer
|
| gptkbp:prescriptionRequired |
true
|
| gptkbp:prevention |
ovulation
|
| gptkbp:regulates |
menstrual cycle
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness weight change |
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:mestranol
|
| gptkbp:bfsLayer |
8
|